{"id":"https://openalex.org/W2128586004","doi":"https://doi.org/10.1093/eurheartj/ehu105","title":"The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial","display_name":"The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial","alternate_titles":[],"publication_year":2014,"publication_date":"2014-03-17","ids":{"openalex":"https://openalex.org/W2128586004","doi":"https://doi.org/10.1093/eurheartj/ehu105","mag":"2128586004","pmid":"https://pubmed.ncbi.nlm.nih.gov/24639426"},"language":"en","primary_location":{"id":"doi:10.1093/eurheartj/ehu105","doi":"https://doi.org/10.1093/eurheartj/ehu105","is_oa":false,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehu105","pdf_url":null,"source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2128586004"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006206326","display_name":"Kausik Kumar Ray","orcid":"https://orcid.org/0000-0003-0508-0954","observed_orcids":["https://orcid.org/0000-0003-0508-0954","https://orcid.org/0000-0002-7166-060X"]},"institutions":[{"id":"https://openalex.org/I165862685","display_name":"St George's, University of London","ror":"https://ror.org/040f08y74","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I165862685","https://openalex.org/I4401726869"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Kausik K. Ray","raw_affiliation_strings":["Cardiovascular Sciences Research Centre, St George's University of London, Cranmer Terrace, London, SW17 OREUK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular Sciences Research Centre, St George's University of London, Cranmer Terrace, London, SW17 OREUK","institution_ids":["https://openalex.org/I165862685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079365240","display_name":"Marc Ditmarsch","orcid":"https://orcid.org/0000-0002-2970-1893","observed_orcids":["https://orcid.org/0000-0002-2970-1893"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marc Ditmarsch","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075595313","display_name":"David G. Kallend","orcid":"https://orcid.org/0000-0003-3680-285X","observed_orcids":["https://orcid.org/0000-0003-3680-285X"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Kallend","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083604698","display_name":"Eric J. Niesor","orcid":"https://orcid.org/0000-0003-2923-2027","observed_orcids":["https://orcid.org/0000-0003-2923-2027"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eric J. Niesor","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028025610","display_name":"Gabriela Such\u00e1nkov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gabriela Suchankova","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007814849","display_name":"Ruchi Upmanyu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113058","display_name":"Roche (United Kingdom)","ror":"https://ror.org/024tgbv41","country_code":"GB","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210113058"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ruchi Upmanyu","raw_affiliation_strings":["Roche Products Ltd, Welwyn Garden City, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Products Ltd, Welwyn Garden City, UK","institution_ids":["https://openalex.org/I4210113058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052212529","display_name":"Judith Anzures\u2010Cabrera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113058","display_name":"Roche (United Kingdom)","ror":"https://ror.org/024tgbv41","country_code":"GB","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210113058"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Judith Anzures-Cabrera","raw_affiliation_strings":["Roche Products Ltd, Welwyn Garden City, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Products Ltd, Welwyn Garden City, UK","institution_ids":["https://openalex.org/I4210113058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013611163","display_name":"Valerie Lehnert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Valerie Lehnert","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042354792","display_name":"Meike Pauly-Evers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Meike Pauly-Evers","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112616035","display_name":"Ingar Holme","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ingar Holme","raw_affiliation_strings":["Department of Endocrinology, Obesity and Preventive Medicine, Oslo University Hospital, Ulleval, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology, Obesity and Preventive Medicine, Oslo University Hospital, Ulleval, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052779150","display_name":"Josef \u0160\u0165\u00e1sek","orcid":"https://orcid.org/0000-0001-5619-9248","observed_orcids":["https://orcid.org/0000-0001-5619-9248"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]}],"countries":["CZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Josef \u0160t\u0301\u00e1sek","raw_affiliation_strings":["Charles University Faculty Hospital, Hradec Kr\u00e1lov\u00e9, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charles University Faculty Hospital, Hradec Kr\u00e1lov\u00e9, Czech Republic","institution_ids":["https://openalex.org/I21250087"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085151864","display_name":"M. W. J. van Hessen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141521","display_name":"Groene Hart Ziekenhuis","ror":"https://ror.org/0582y1e41","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210141521"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maarten W. J. van Hessen","raw_affiliation_strings":["Groene Hart Ziekenhuis, Gouda, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groene Hart Ziekenhuis, Gouda, The Netherlands","institution_ids":["https://openalex.org/I4210141521"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002068723","display_name":"Peter J.H. Jones","orcid":"https://orcid.org/0000-0001-5887-2846","observed_orcids":["https://orcid.org/0000-0001-5887-2846"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Jones","raw_affiliation_strings":["Baylor College of Medicine, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine, Houston, TX, USA","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"last","author":{"id":null,"display_name":"on behalf of the dal-ACUTE Investigators","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"on behalf of the dal-ACUTE Investigators","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5006206326"],"corresponding_institution_ids":["https://openalex.org/I165862685"],"apc_list":{"value":5240,"currency":"EUR","value_usd":5922},"apc_paid":null,"fwci":11.7725,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.99057812,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"35","issue":"27","first_page":"1792","last_page":"1800"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.8457000255584717,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.8457000255584717,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.14139999449253082,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12975","display_name":"Paraoxonase enzyme and polymorphisms","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cholesteryl-ester-transfer-protein-inhibition","display_name":"cholesteryl ester transfer protein inhibition","score":0.9440000057220459},{"id":"https://openalex.org/keywords/dalcetrapib","display_name":"dalcetrapib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.9710000157356262},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.8980000019073486},{"id":"https://openalex.org/keywords/hdl-function","display_name":"HDL function","score":0.8880000114440918},{"id":"https://openalex.org/keywords/apolipoprotein-a-i","display_name":"apolipoprotein A-I","score":0.9139999747276306},{"id":"https://openalex.org/keywords/cholesterol-efflux","display_name":"cholesterol efflux","score":0.9399999976158142},{"id":"https://openalex.org/keywords/abca1","display_name":"ABCA1","score":0.8379999995231628},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.7689999938011169},{"id":"https://openalex.org/keywords/serum-lipids","display_name":"serum lipids","score":0.36800000071525574}],"concepts":[{"id":"https://openalex.org/C45505151","wikidata":"https://www.wikidata.org/wiki/Q424706","display_name":"Cholesterylester transfer protein","level":4,"score":0.9594638347625732},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7527520656585693},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.7421166896820068},{"id":"https://openalex.org/C2777704780","wikidata":"https://www.wikidata.org/wiki/Q21115210","display_name":"ABCA1","level":4,"score":0.7227041721343994},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6998549699783325},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.6554054021835327},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.623236894607544},{"id":"https://openalex.org/C110459506","wikidata":"https://www.wikidata.org/wiki/Q7318217","display_name":"Reverse cholesterol transport","level":4,"score":0.614931583404541},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.5752830505371094},{"id":"https://openalex.org/C2780541478","wikidata":"https://www.wikidata.org/wiki/Q410020","display_name":"High-density lipoprotein","level":3,"score":0.5242252945899963},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.4964929223060608},{"id":"https://openalex.org/C2777698277","wikidata":"https://www.wikidata.org/wiki/Q266018","display_name":"Acute coronary syndrome","level":3,"score":0.4511978030204773},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32154279947280884},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18358907103538513},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.14342841506004333},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12570470571517944},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.12059718370437622},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000789","descriptor_name":"Angina, Unstable","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001053","descriptor_name":"Apolipoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002097","descriptor_name":"C-Reactive Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004952","descriptor_name":"Esters","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008074","descriptor_name":"Lipoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008076","descriptor_name":"Cholesterol, HDL","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013438","descriptor_name":"Sulfhydryl Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050356","descriptor_name":"Lipid Metabolism","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D053480","descriptor_name":"Cholesterol Ester Transfer Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D064286","descriptor_name":"ATP Binding Cassette Transporter 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/eurheartj/ehu105","doi":"https://doi.org/10.1093/eurheartj/ehu105","is_oa":false,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehu105","pdf_url":null,"source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},{"id":"pmid:24639426","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24639426","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European heart journal","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W57115353","https://openalex.org/W1240353884","https://openalex.org/W1522563257","https://openalex.org/W1986846286","https://openalex.org/W2010525799","https://openalex.org/W2014558113","https://openalex.org/W2018245065","https://openalex.org/W2019482587","https://openalex.org/W2025713717","https://openalex.org/W2048760408","https://openalex.org/W2055823448","https://openalex.org/W2061250936","https://openalex.org/W2075388292","https://openalex.org/W2095507444","https://openalex.org/W2095801584","https://openalex.org/W2099869131","https://openalex.org/W2101975847","https://openalex.org/W2107952252","https://openalex.org/W2118825330","https://openalex.org/W2119120197","https://openalex.org/W2126816601","https://openalex.org/W2127427274","https://openalex.org/W2131646844","https://openalex.org/W2138935816","https://openalex.org/W2145813488","https://openalex.org/W2155110384","https://openalex.org/W2160594770","https://openalex.org/W2189396613","https://openalex.org/W4292856638"],"related_works":["https://openalex.org/W2118825330","https://openalex.org/W3135118576","https://openalex.org/W2563743855","https://openalex.org/W2057930014","https://openalex.org/W1542346667","https://openalex.org/W2053019417","https://openalex.org/W2014558113","https://openalex.org/W4273006","https://openalex.org/W2131620609","https://openalex.org/W4233274178"],"abstract_inverted_index":{"AIMS:":[0],"The":[1,31,52,122],"effects":[2],"of":[3,15,49,71,213,226,234],"cholesteryl":[4],"ester":[5],"transfer":[6],"protein":[7],"(CETP)":[8],"inhibition":[9,183],"on":[10],"lipids,":[11],"inflammation,":[12],"and":[13,74,80,85,92,137,142,155,174,202,220,231],"markers":[14,70],"high-density":[16],"lipoprotein":[17,179],"(HDL)":[18],"function,":[19,73],"following":[20],"an":[21,50,106],"acute":[22],"coronary":[23],"syndrome":[24],"(ACS),":[25],"are":[26],"unknown.":[27],"METHODS":[28],"AND":[29],"RESULTS:":[30],"dal-ACUTE":[32],"study":[33],"randomized":[34],"300":[35],"patients":[36],"(1":[37],":":[38],"1)":[39],"to":[40,228],"dalcetrapib":[41,128,185],"600":[42],"mg/day":[43],"or":[44],"placebo":[45],"within":[46],"1":[47],"week":[48],"ACS.":[51],"primary":[53],"endpoint":[54],"was":[55,196],"per":[56],"cent":[57],"change":[58],"in":[59,108,119,124,134,149,165,217],"HDL-cholesterol":[60],"(HDL-C)":[61],"after":[62,101],"4":[63,102],"weeks.":[64],"Secondary":[65],"endpoints":[66],"included":[67],"apolipoprotein":[68,81,135,172,200],"levels,":[69,222],"HDL":[72,218],"inflammation.":[75],"Dalcetrapib":[76],"treatment":[77],"increased":[78,197,206],"HDL-C":[79,138,175,195,221],"A1":[82,136,173,201],"by":[83,96,198,208],"33.7":[84],"11.8%,":[86],"respectively":[87],"(both":[88],"P":[89],"<":[90],"0.001)":[91],"total":[93,125,203],"cholesterol":[94,187],"efflux":[95,126,158,168,204],"9.5%":[97],"(P":[98],"=":[99,140,152],"0.003)":[100],"weeks,":[103],"principally":[104,189],"via":[105,190],"increase":[107,123,148],"non-ATP-binding":[109],"cassette":[110],"transporter":[111],"(ABC)":[112],"A1-mediated":[113],"efflux,":[114,188],"without":[115],"statistically":[116],"significant":[117],"changes":[118],"pre-\u03b21-HDL":[120,150,163],"levels.":[121,176],"with":[127,132,162,171,184],"correlated":[129,159,169],"most":[130,160],"strongly":[131,161],"increases":[133],"(r":[139,151],"0.46":[141],"0.43,":[143],"respectively)":[144],"rather":[145],"than":[146],"the":[147,211,232],"0.32).":[153],"Baseline":[154],"on-treatment":[156],"ABCA1-mediated":[157],"levels;":[164],"contrast,":[166],"non-ABCA1-mediated":[167,192],"better":[170],"CONCLUSIONS:":[177],"High-density":[178],"raised":[180],"through":[181],"CETP":[182],"improves":[186],"a":[191],"pathway.":[193],"While":[194],"one-third,":[199],"were":[205],"only":[207],"one-tenth,":[209],"supporting":[210],"concept":[212],"dissociation":[214],"between":[215],"improvements":[216],"function":[219],"which":[223],"may":[224],"be":[225],"relevance":[227],"ongoing":[229],"trials":[230],"development":[233],"therapeutic":[235],"interventions":[236],"targeting":[237],"HDL.":[238]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2128586004","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":18},{"year":2015,"cited_by_count":23},{"year":2014,"cited_by_count":7}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
